Stroke-associated pneumonia: from immunodepression to bedside management and future research directions
Abstract
Stroke-associated pneumonia (SAP) is one of the most frequent complications after acute stroke, affecting approximately one in eight stroke patients. Besides prolonged hospitalisation and increased healthcare costs, it is also a major risk factor for mortality and poor functional recovery. The pathophysiology of SAP is driven by two converging processes: impaired local airway defence due to dysphagia as well as reduced airway clearance reflexes, and systemic stroke-induced immunodepression driven by dysfunction of the autonomic nervous system. While post-stroke immunodepression is a major risk factor for SAP, it might limit unwanted autoimmune responses within the brain. Conversely, SAP itself may drive neuroinflammation and contribute to post-stroke cognitive impairment. Despite its clinical importance, high-quality evidence to guide practice on prevention, diagnosis, and treatment of SAP remains scarce and guideline recommendations are mostly based on expert consensus. Diagnosis of SAP is suggested to be based on standardised clinical criteria supported by chest radiography and C-reactive protein as an adjunct where uncertainty persists. After diagnosis, guidelines suggest prompt empirical antibiotic therapy according to local protocols. In contrast, preventive antibiotics, even for high-risk patients, neither improve clinical outcome nor reduce SAP frequency. Currently recommended preventive strategies for SAP therefore mostly focus on dysphagia management and early…
Read the paper
Related studies
- Length of stay and mortality associated with healthcare-associated urinary tract infections: a multi-state model
- Development and Validation of a Calculator for Estimating the Probability of Urinary Tract Infection in Young Febrile Children
- Effect of Missing Data Imputation on Deep Learning Prediction Performance for Vesicoureteral Reflux and Recurrent Urinary Tract Infection Clinical Study
- Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial
- Randomized Clinical Trial Using Sterile Single Use and Reused Polyvinylchloride Catheters for Intermittent Catheterization with a Clean Technique in Spina Bifida Cases: Short-Term Urinary Tract Infection Outcomes
- Urinary tract infection after stroke: A narrative review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.